Earnings Preview: It’s a mixed bag for Teva Pharma in Q3

Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to post its third-quarter 2018 earnings on Nov 1, before the opening bell. So, what is in store for the generic drugmaker’s shares that have moved 4% up this year vs. the industry’s 5.8% dip? Teva is in a good place now, since it beat expectations in three … Continue reading Earnings Preview: It’s a mixed bag for Teva Pharma in Q3